Close

AzurRx BioPharma (AZRX) Granted French Regulatory Approval in Partnership with Mayoly Spindler to add Clinical Site in France for Phase IIa Study of MS1819-SD

January 18, 2018 8:08 AM EST Send to a Friend
AzurRx BioPharma, Inc. (NASDAQ: AZRX) announced today that in partnership with Mayoly Spindler, a French pharmaceutical company, they have received ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login